The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg.
Open accessAbstract
Amino acid deletion and mutagenesis experiments have indicated that the sequences Glu-Leu-Arg (ELR) preceding the first cysteine at the N terminus of interleukin 8 (IL-8) is required for receptor binding and neutrophil activation. Platelet factor 4 (PF4) is structurally related to IL-8 (35% sequence identity) but lacks the N-terminal ELR sequence and comparable effects on neutrophils. We introduced the ELR sequence at the N terminus of PF4 and found that the modified protein was a potent neutrophil activator and attractant. On the other hand, when the ELR sequence was introduced into the corresponding positions of two other proteins related to IL-8, gamma-interferon-inducible protein IP10 and monocyte chemoattractant protein 1, neither of them acquired neutrophil-activating properties, indicating that besides ELR additional structural determinants of IL-8 and PF4 are important for binding to IL-8 receptors. The conservation of these binding determinants suggests that PF4 may have evolved from a neutrophil activating protein.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsushima, K., Morishita, K., Yoshimura, T., Lavu, S., Kobayashi, Y., Lew, W., Appella, E., Kung, H. F., Leonard, E. J., & Oppenheim, J. J. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.6.1883 · Cited by 1,021
Interleukin‐8, a chemotactic and inflammatory cytokine
Baggiolini, M., & Clark-Lewis, I. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80909-z · Cited by 989
Self-citationLuster, A. D., Unkeless, J. C., & Ravetch, J. V. (1985) · Nature · doi:10.1038/315672a0 · Cited by 944
Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides
Maione, T. E., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S. I., Carson, H. F., & Sharpe, R. J. (1990) · Science · doi:10.1126/science.1688470 · Cited by 697
Biology of the rantes/sis cytokine family
Schall, T. J. (1991) · Cytokine · doi:10.1016/1043-4666(91)90013-4 · Cited by 673
Human monocyte chemoattractant protein-1 (MCP-1)
Leonard, E. J., & Yoshimura, T. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90035-8 · Cited by 663
A novel neutrophil-activating factor produced by human mononuclear phagocytes.
Peveri, P., Walz, A., Dewald, B., & Baggiolini, M. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.5.1547 · Cited by 647
Self-citationYoshimura, T., Yuhki, N., Moore, S. K., Appella, E., Lerman, M. I., & Leonard, E. J. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)80590-3 · Cited by 589
Three-dimensional structure of interleukin 8 in solution
Clore, G. M., Appella, E., Yamada, M., Matsushima, K., & Gronenborn, A. M. (1990) · Biochemistry · doi:10.1021/bi00459a004 · Cited by 440
Platelet factor 4 is chemotactic for neutrophils and monocytes.
Deuel, T. F., Senior, R. M., Chang, D., Griffin, G. L., Heinrikson, R. L., & Kaiser, E. T. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.7.4584 · Cited by 431
Cited by
Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S.-I., Kitamura, Y., Yoshida, N., Kikutani, H., & Kishimoto, T. (1996) · Nature · doi:10.1038/382635a0 · Cited by 2,338
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909 · Cited by 1,984
lnterleukin-8 and Related Chemotactic Cytokines—CXC and CC Chemokines
Baggiolini, M., Dewald, B., & Moser, B. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60509-x · Cited by 1,671
Self-citationThe Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis
Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27348 · Cited by 1,222
The Molecular Biology of Leukocyte Chemoattractant Receptors
Murphy, P. M. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.003113 · Cited by 1,195
Loetscher, M., Gerber, B., Loetscher, P., Jones, S. A., Piali, L., Clark-Lewis, I., Baggiolini, M., & Moser, B. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.963 · Cited by 1,193
Self-citationCole, K. E., Strick, C. A., Paradis, T. J., Ogborne, K. T., Loetscher, M., Gladue, R. P., Lin, W., Boyd, J. G., Moser, B., Wood, D. E., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2009 · Cited by 870
Self-citationBachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis
Brat, D. J., Bellail, A. C., & Van Meir, E. G. (2005) · Neuro-Oncology · doi:10.1215/s1152851704001061 · Cited by 760
Chemokines in pathology and medicine
Baggiolini, M. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00867.x · Cited by 677
Self-citationThe role of CXC chemokines and their receptors in cancer
Vandercappellen, J., Van Damme, J., & Struyf, S. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.050 · Cited by 643
Addison, C. L., Daniel, T. O., Burdick, M. D., Liu, H., Ehlert, J. E., Xue, Y. Y., Buechi, L., Walz, A., Richmond, A., & Strieter, R. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.5269 · Cited by 575
Interleukin-8: An evolving chemokine
Matsushima, K., Yang, D., & Oppenheim, J. J. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155828 · Cited by 520
Angiogenesis: Implications for rheumatoid arthritis
Koch, A. E. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199806)41:6<951::aid-art2>3.0.co;2-d · Cited by 504
Mach, F., Sauty, A., Iarossi, A. S., Sukhova, G. K., Neote, K., Libby, P., & Luster, A. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6993 · Cited by 464
Signals and Receptors Involved in Recruitment of Inflammatory Cells
Ben-Baruch, A., Michiel, D. F., & Oppenheim, J. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.20.11703 · Cited by 411
Cytokines and Chemokines in Mycobacterium tuberculosis Infection
Domingo-Gonzalez, R., Prince, O., Cooper, A., & Khader, S. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0018-2016 · Cited by 404
Interleukin-8 and the chemokine family
Baggiolini, M., Loetscher, P., & Moser, B. (1995) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(94)00088-6 · Cited by 400
Self-citationSauty, A., Dziejman, M., Taha, R. A., Iarossi, A. S., Neote, K., Garcia-Zepeda, E. A., Hamid, Q., & Luster, A. D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3549 · Cited by 376
Structure-activity relationships of chemokines
Clark-Lewis, I., Kim, K.-S., Rajarathnam, K., Gong, J.-H., Dewald, B., Moser, B., Baggiolini, M., & Sykes, B. D. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.5.703 · Cited by 361
Self-citationHieshima, K., Imai, T., Opdenakker, G., Van Damme, J., Kusuda, J., Tei, H., Sakaki, Y., Takatsuki, K., Miura, R., Yoshie, O., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5846 · Cited by 358
Neutrophil Activation by Monomeric Interleukin-8
Rajarathnam, K., Sykes, B. D., Kay, C. M., Dewald, B., Geiser, T., Baggiolini, M., & Clark-Lewis, I. (1994) · Science · doi:10.1126/science.8140420 · Cited by 356
Self-citationDifferential binding of chemokines to glycosaminoglycan subpopulations
Witt, D. P., & Lander, A. D. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00088-9 · Cited by 344
Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases
Cheng, Y., Ma, X.-L., Wei, Y.-Q., & Wei, X.-W. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.01.005 · Cited by 344
Regulation of Macrophage Chemokine Expression by Lipopolysaccharide In Vitro and In Vivo
Kopydlowski, K. M., Salkowski, C. A., Cody, M. J., van Rooijen, N., Major, J., Hamilton, T. A., & Vogel, S. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1537 · Cited by 313
Structure-function relationships of antimicrobial peptides
Hwang, P. M., & Vogel, H. J. (1998) · Biochemistry and Cell Biology · doi:10.1139/bcb-76-2-3-235 · Cited by 313
The Role of Platelets in Antimicrobial Host Defense
Yeaman, M. R. (1997) · Clinical Infectious Diseases · doi:10.1086/516120 · Cited by 308
Depletion of CXCR2 Inhibits Tumor Growth and Angiogenesis in a Murine Model of Lung Cancer
Keane, M. P., Belperio, J. A., Xue, Y. Y., Burdick, M. D., & Strieter, R. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2853 · Cited by 305
Gong, J. H., & Clark-Lewis, I. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.631 · Cited by 273
Self-citationCXC CHEMOKINE RECEPTOR EXPRESSION ON HUMAN ENDOTHELIAL CELLS
Murdoch, C., Monk, P. N., & Finn, A. (1999) · Cytokine · doi:10.1006/cyto.1998.0465 · Cited by 271
Chemokines in teleost fish species
Alejo, A., & Tafalla, C. (2011) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2011.03.011 · Cited by 263
CXC chemokines located in the 4q21 region are up-regulated in breast cancer
Bieche, I., Chavey, C., Andrieu, C., Busson, M., Vacher, S., Le Corre, L., Guinebretiere, J.-M., Burlinchon, S., Lidereau, R., & Lazennec, G. (2007) · Endocrine Related Cancer · doi:10.1677/erc.1.01301 · Cited by 183
CXC Chemokines Function as a Rheostat for Hepatocyte Proliferation and Liver Regeneration
Wilson, G. C., Kuboki, S., Freeman, C. M., Nojima, H., Schuster, R. M., Edwards, M. J., & Lentsch, A. B. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120092 · Cited by 29
Metadata
- Authors
- Clark-Lewis, I., Dewald, B., Geiser, T., Moser, B., & Baggiolini, M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1993-04-15
- Volume
- 90
- Issue
- 8
- Pages
- 3574-3577
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2062521099
- Cited by
- 257
- References
- 30
- FWCI
- 5.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.